Published in
Elsevier, Lung Cancer, (153), p. 150-157, 2021
DOI: 10.1016/j.lungcan.2021.01.018
Links
Tools
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: first clinical experience
Journal article published in 2021 by
Florian Eichhorn 
,
Laura V. Klotz,
Mark Kriegsmann ,
Helge Bischoff ,
Marc A. Schneider ,
Thomas Muley ,
Katharina Kriegsmann,
Uwe Haberkorn,
Claus Peter Heussel,
Rajkumar Savai,
Inka Zoernig,
Dirk Jaeger,
Michael Thomas ,
Hans Hoffmann,
Hauke Winter
and other authors.
,
Laura V. Klotz,
Mark Kriegsmann ,
Helge Bischoff ,
Marc A. Schneider ,
Thomas Muley ,
Katharina Kriegsmann,
Uwe Haberkorn,
Claus Peter Heussel,
Rajkumar Savai,
Inka Zoernig,
Dirk Jaeger,
Michael Thomas ,
Hans Hoffmann,
Hauke Winter
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 